MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

15 Jul 2026 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.25
Dr. Reddys Labs. 1200.50
Cipla 1332.40
Lupin 2010.95
Zydus Lifesciences 1131.60
View more..